Home
Alembic Pharmaceuticals Limited
Press Release Sep 27 2024
Business
Sep 27 2024
3 min read

Press Release Sep 27 2024

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 27, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg".

View Attachment